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Panchsakar Churna is the composition of Cassia angustifolia, Terminalia chebula, 
Zingiber officinale, Foeniculum vulgare and Saindhava lavana. Aqueous extract of churna 
was used to investigate antioxidant activity by ferrous ion chelating assay and ferric 
reducing power and alpha amylase inhibition activity by dinitrosalicylic acid method 
(DNSA). Aqueous extract of churna showed maximum ferrous chelating activity - 42.01 
and ferric reducing power - 1.5 and 83.33% of inhibition protein denaturation at 1000 
µg/ml. Panchsakar churna showed significant antioxidant and alpha amylase inhibition 
activities. Acta Medica Medianae 2013;52(4):12-14. 
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Introduction 
 
  Panchsakar Churna, an Ayurvedic poly-
herbomineral formulation, consists of Cassia angu-
stifolia, Foeniculum vulgare, Terminalia chebula, 
Zingiber officinale and Saindhava Lavana, tradi-
tionally used for managing constipation, rheu-
matoid arthritis, haemorrhoids, abdominal pain, 
flatulence, assimilatory disorder and rheumatic 
conditions, all diseases of Kapha Dosha origin, 
improves digestion and ensures timely evacu-
ation of faeces, improves liver functions, hyper-
acidity, heart burn and acidic belching (1). 
The main aim of the present study was to 
investigate antioxidant and alpha-amylase inhi-
bition  activity of aqueous extract of Panchsakar 
Churna. 
 
Antioxidant activity studies 
 
Ferric reducing power  
 
The ferric reducing power of the aqueous 
extract of Panchsakar Churna (APC) was deter-
mined by using potassium ferricyanide–ferric 
chloride method (2). Different concentrations 
(100–1000 μg/ml) of extracts were added to 2.5 
ml 0.2 M phosphate buffer (pH 6.6) and 2.5 ml 
potassium ferricyanide (1%). The mixtures were 
incubated at 50°C for 20 min, after which 2.5 ml 
trichloroacetic acid (10%) were added. Two and 
one half milliliters of the mixture were taken and 
mixed with 2.5 ml water and 0.5 ml 1% FeCl3. 
The absorbance at 700 nm was measured after 
allowing the solution to stand for 30 min. A graph 
of absorbance vs. extract concentration was 
plotted to observe the reducing power.  
 
Ferrous ion chelating activity 
 
The chelating ability of the aqueous extract 
of  Panchsakar Churna (APC) was determined 
according to the modified method of Minotti and 
Aust, 1987 (3). In this assay, the plant extract 
binds Fe2+ ion generated in vitro using 500 uM 
iron (ii) sulphate as ion donor. 0.2ml of sample of 
different concentration (100–1000 μg/ml) of the 
churna extract was mixed with 0.336ml of Tris 
HCl (0.1M, pH7.4), followed by the addition of 
0.436ml (saline, 0.9% NaCl w/v). The mixture 
was left to stand at room temperature for 5 min. 
0.26ml of 0.25% aqueous 1,10-phenanthroline 
were added. The absorbance of the solution was 
read on uv/visible spectrophotometer at 510 nm 
against control which consists of Tris HCl, saline 
and phenanthroline without the plant extract.   
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Alpha amylase Inhibition assay (3, 5-dinitro-
salicylic acid method) 
 
The inhibition assay was performed according 
to Miller (4) using the DNS method. Aqueous 
extract of Panchsakar  Churna (APC) of varied 
concentrations in 500μl were added to 500 μL of 
0.02 M sodium phosphate buffer (pH6.9 containing 
6 mM sodium chloride) containing 0.04 units of 
alpha amylase solution and were incubated at 
37°C for 10 min, followed by addition of 500 μL 
of a 1% starch solution in 0.02 M sodium 
phosphate buffer (pH6.9) in all the test tubes. The 
reaction was stopped with 1.0 ml of 3,5 DNSA 
reagent. The test tubes were then incubated in a 
boiling bath water for 5 min, cooled at room 
temperature. The reaction mixture was then 
diluted after adding 10 ml distilled water and 
absorbance was measured at 540 nm. The 
control samples were also prepared accordingly 
without any plant extracts and were compared 
with the test samples containing various concen-
trations  of the plant extracts prepared with 
different solvents. The results were expressed as 
% inhibition calculated using the formula: 
 
 
 
 
Result and discussion 
 
Iron is an important trace element of the 
body, being found in a functional form in hemo-
globin, myoglobin, the cytochromes, enzymes 
with iron sulphur complexes and other iron-
dependent enzymes (5). Iron has the unique 
ability to alter its oxidation and redox states in 
response to liganding, which makes it essential 
for various cellular processes (6). The cells 
maintain the free iron concentration to a 
minimum required level to avoid toxic effects of 
excess iron. However, in some situations the iron 
balance is disrupted and results in iron overload 
which is associated with the oxidative stress 
inducing  several health problems including 
anemias, heart failure, liver cirrhosis, diabetes, 
arthritis, depression, infertility, and cancer (7). 
The body lacks any effective means to excrete 
excessive iron and therefore the interest has 
been raised to develop the potent chelating agent 
capable of complexing with iron and promoting its 
excretion (8,9). Graph 1 shows ferrous chelating 
activity of aqueous extract of panchsakra churna.  
Ferric reduction is frequently used as a 
marker of electron-donating activity and considered 
as a significant mechanism of phenolic anti-
oxidant action (10). In the ferric reducing anti-
oxidant power (FRAP) assay, this Fe2+ complex 
can be determined at 700 nm by evaluating the 
 
Graph 1. Ferric reducing activity of Pancsakar Churna 
 
Graph 2. Ferrous chelating activity of Panchsakar 
Churna 
 
Graph 3. α-amylase inhibition activity of Panchsakar 
Churna 
 
formation of Perl's Prussian blue in the extracts, if 
any, which would result in reducing Fe3+ to Fe2+ 
by donating an electron. Amount of the reductive 
ability is directly proportional to the absorbance 
of the APC at 700 nm (11). This is especially 
important in neurologic disorders accompanied by 
increased oxidative damage of neurons (12). 
Graph 2 shows the ferric reducing power of APC. 
Although the acute effects of a-amylase 
inhibitors may appear to have therapeutic benefit 
in patients suffering from diabetes mellitus, 
obesity and other diseases of insulin resistance, 
chronic administration in animal models has been 
shown to induce adverse effects including dele-
terious histological changes to the pancreas (13). 
Graph 3 shows Panchsakra Churna inhibition of 
α -amylase enzyme.  
Panchsakra Churna has shown potent anti-
oxidant and α-amylase inhibitory activities. Natural 
health products were clearly indicated as a 
promising avenue for the prevention of chronic 
diseases (14). 
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IN VITRO ANTIOKSIDACIONE I AKTIVNOSTI PANCHSAKAR CHURNA 
U INHIBICIJI α-AMILAZE  
 
Ashok Kumar B.S., Gopi Setty Saran, Firdose Banu, Harshada R., 
Archana P.G. 
 
 
U sastavu panchsakar churna  nalaze se Cassia angustifolia, Terminalia chebula, 
Zingiber officinale, Foeniculum vulgare i Saindhava    lavana. Vodeni ekstrakt churna 
korišćen je da bi se ispitalo antioksidaciono dejstvo pomoću helat analize jonom gvožđa i 
smanjene  moći  gvožđa,  kao  i  dejstvo  inhibicije  alfa  amilaze  pomoću  metoda 
dinitrosalicilnom kiselinom. Vodeni ekstrakt churna je pokazao maksimalno dejstvo helata 
gvožđ a  o d  4 2 . 0 1  i  s m a n j e n o  d e j s t v o  g v o ž đ a  o d  1 . 5  i  83.33% inhibicije denaturacije 
proteina na 1000 µg/ml. Panchsakar churna je pokazao antioksidaciono i inhibitorno dejstvo 
alfa amilaze. Acta Medica Medianae 2013;52(4):12-14. 
 
Ključne reči: Panchsakar churna, inhibitorno dejstvo alfa amilaze, helaciono dejstvo  
gvožđa 
 